Serum uric acid and gout: from the past to molecular biology.

Détails

ID Serval
serval:BIB_124D30A412D2
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Serum uric acid and gout: from the past to molecular biology.
Périodique
Current Medical Research and Opinion
Auteur⸱e⸱s
Punzi L., So A.
ISSN
1473-4877 (Electronic)
ISSN-L
0300-7995
Statut éditorial
Publié
Date de publication
2013
Volume
29
Numéro
Suppl. 3
Pages
3-8
Langue
anglais
Notes
Publication types: Journal ArticlePublication Status: ppublish
Résumé
Abstract Objectives: This review will briefly present the epidemiology and risk factors of gout, with a focus on recent advances. Methods: Key papers for inclusion were identified by a PubMed search, and articles were selected according to their relevance for the topic, according to authors' judgment. Results and conclusions: Gout therapy has remained very much unchanged for the last 50 years, but recently we have seen the approval of another gout treatment: the xanthine oxidase inhibitor febuxostat, and several new drugs are now in the late stages of clinical testing. Together with our enhanced level of understanding of the pathophysiology of the inflammatory process involved, we are entering a new era for the treatment of gout.
Pubmed
Web of science
Création de la notice
06/06/2013 18:09
Dernière modification de la notice
20/08/2019 12:40
Données d'usage